Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. Approval
Follow us on Twitter: @GoAfricaNetwork The first complete treatment for hepatitis C that requires taking only one daily pill won approval Friday from the Food and Drug Administration. The drug, called Harvoni and developed by Gilead Sciences, could shorten the duration of treatment and provide the first all-oral regimen for many patients. The new drug […]
Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. Approval Read More »